| Product Code: ETC7916936 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Obesity Drugs Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Obesity Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Obesity Drugs Market - Industry Life Cycle |
3.4 Latvia Obesity Drugs Market - Porter's Five Forces |
3.5 Latvia Obesity Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Obesity Drugs Market Revenues & Volume Share, By Age, 2021 & 2031F |
3.7 Latvia Obesity Drugs Market Revenues & Volume Share, By Gender, 2021 & 2031F |
3.8 Latvia Obesity Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Latvia Obesity Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity in Latvia |
4.2.2 Growing awareness about the health risks associated with obesity |
4.2.3 Rising disposable income leading to increased spending on healthcare |
4.3 Market Restraints |
4.3.1 Stringent regulatory approvals for obesity drugs |
4.3.2 Limited availability of effective obesity drugs in the market |
5 Latvia Obesity Drugs Market Trends |
6 Latvia Obesity Drugs Market, By Types |
6.1 Latvia Obesity Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Obesity Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Obesity Drugs Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.1.4 Latvia Obesity Drugs Market Revenues & Volume, By OTC Drugs, 2021- 2031F |
6.2 Latvia Obesity Drugs Market, By Age |
6.2.1 Overview and Analysis |
6.2.2 Latvia Obesity Drugs Market Revenues & Volume, By Children, 2021- 2031F |
6.2.3 Latvia Obesity Drugs Market Revenues & Volume, By Adult, 2021- 2031F |
6.2.4 Latvia Obesity Drugs Market Revenues & Volume, By Old, 2021- 2031F |
6.3 Latvia Obesity Drugs Market, By Gender |
6.3.1 Overview and Analysis |
6.3.2 Latvia Obesity Drugs Market Revenues & Volume, By Male, 2021- 2031F |
6.3.3 Latvia Obesity Drugs Market Revenues & Volume, By Female, 2021- 2031F |
6.4 Latvia Obesity Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Latvia Obesity Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Latvia Obesity Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 Latvia Obesity Drugs Market Revenues & Volume, By Online, 2021- 2031F |
7 Latvia Obesity Drugs Market Import-Export Trade Statistics |
7.1 Latvia Obesity Drugs Market Export to Major Countries |
7.2 Latvia Obesity Drugs Market Imports from Major Countries |
8 Latvia Obesity Drugs Market Key Performance Indicators |
8.1 Number of prescriptions for obesity drugs in Latvia |
8.2 Percentage of healthcare professionals recommending obesity drugs |
8.3 Patient adherence rate to obesity drug treatment |
9 Latvia Obesity Drugs Market - Opportunity Assessment |
9.1 Latvia Obesity Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Obesity Drugs Market Opportunity Assessment, By Age, 2021 & 2031F |
9.3 Latvia Obesity Drugs Market Opportunity Assessment, By Gender, 2021 & 2031F |
9.4 Latvia Obesity Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Latvia Obesity Drugs Market - Competitive Landscape |
10.1 Latvia Obesity Drugs Market Revenue Share, By Companies, 2024 |
10.2 Latvia Obesity Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here